JACN
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Golik, A.
Right arrow Articles by Weissgarten, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Golik, A.
Right arrow Articles by Weissgarten, J.

Effects of Captopril and Enalapril on Zinc Metabolism in Hypertensive Patients

Ahuva Golik, MD, Ronit Zaidenstein, MD, Victor Dishi, MD, Alexander Blatt, MD, Natan Cohen, MD, Gad Cotter, Silvia Berman, MD and Joshua Weissgarten, MD

Department of Internal Medicine "A", Internal Medicine "F" (N.C.), Assaf Harofeh Medical Center, Zerifin, affiliated with the Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, ISRAEL
Department of Nephrology (S.B., J.W.), Assaf Harofeh Medical Center, Zerifin, affiliated with the Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, ISRAEL



View larger version (21K):

[in a new window]
  		Fig. 1. Serum zinc levels (µg/dl) in the captopril-treated, enalapril-treated and control groups.

 


View larger version (25K):

[in a new window]
  		Fig. 2. Urinary zinc excretion (µg/24 hour) in the captopril-treated enalapril-treated and control groups.

 


View larger version (18K):

[in a new window]
  		Fig. 3. Monocyte zinc content (nmol/mg protein) in the captopril-treated, enalapril-treated and control groups.

 




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by the American College of Nutrition.